Figure S4 from Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma
Year: 2025
Type: other
Abstract: Dose Responses and Bliss Prediction of Additivity for MG63.3-GFP sarcospheres in secondary screen
Authors: Emily E. Seiden, Spencer M. Richardson, Leah A. Everitt, Gabrielle J. Knafler, Alyssa L. Walker, Venetia A. Whiteside, Divya Pillutla, Shrey Ramnath, Gavin P. Kinsella, Piper A. Wilburn, James D. Buschbach, Deep A. Gandhi, M. Reza Saadatzadeh, L. Daniel Wurtz, Patrick J. Getty, Sheldon L. Padgett, Rance M. Gamblin, Michael O. Childress, Christopher M. Fulkerson, Maegan L. Capitano, Karen E. Pollok, Christopher D. Collier, Edward M. Greenfield
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4415191608
Cites:
Cited by:
Related to: